Single-center retrospective evaluation of a polymerase chain reaction-based pneumonia panel on antibiotic therapy optimization at a community hospital.
Luke Manda, Anthony Wasielewski, Nishika Patel, Timothy P Gauthier
{"title":"Single-center retrospective evaluation of a polymerase chain reaction-based pneumonia panel on antibiotic therapy optimization at a community hospital.","authors":"Luke Manda, Anthony Wasielewski, Nishika Patel, Timothy P Gauthier","doi":"10.1017/ash.2025.57","DOIUrl":null,"url":null,"abstract":"<p><p>The implementation of a polymerase chain reaction-based pneumonia panel was associated with actionable results in 87% of 384 cases. In a population of mostly elderly non-intensive care unit patients with sputum samples, opportunities for antibiotic stewardship included streamlining for atypical bacteria, <i>Pseudomonas aeruginosa</i>, and methicillin-resistant <i>Staphylococcus aureus</i> coverage, with occasional opportunities to escalate antibiotic therapy.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"5 1","pages":"e91"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11986877/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial stewardship & healthcare epidemiology : ASHE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/ash.2025.57","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The implementation of a polymerase chain reaction-based pneumonia panel was associated with actionable results in 87% of 384 cases. In a population of mostly elderly non-intensive care unit patients with sputum samples, opportunities for antibiotic stewardship included streamlining for atypical bacteria, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus coverage, with occasional opportunities to escalate antibiotic therapy.